MicroRNA-451 Attenuates the Inflammatory Response of Activated Microglia by Downregulating Nucleotide Binding

Zhou Hong1, Jiaqi Cheng2, Yong Ye3

  • 1Medical School of Nantong University, Nantong, China; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong, China.

World Neurosurgery
|September 10, 2022
PubMed
Abstract

Insights

MicroRNA-451 (miR-451) suppresses the NLRP3 inflammasome pathway, reducing inflammation and potential secondary neuronal damage following spinal cord injury.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Spinal cord injury often results from spinal surgery, leading to blood-brain barrier disruption and neuroinflammation.
  • Nucleotide binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasomes are key mediators of inflammation in the central nervous system.
  • MicroRNA-451 (miR-451) has been implicated in regulating inflammatory conditions.

Purpose of the Study:

  • To investigate the role of miR-451 in regulating NLRP3 inflammasome activation in microglial cells.
  • To determine if miR-451 can modulate the inflammatory response after spinal cord injury.

Main Methods:

  • Bioinformatics analysis identified NLRP3 as a direct target of miR-451.
  • Dual-luciferase reporter gene assays confirmed the interaction between miR-451 and NLRP3.
  • Microglial cells were activated with lipopolysaccharides to assess miR-451's effect on NLRP3 production.

Main Results:

  • Lipopolysaccharide stimulation induced NLRP3 inflammasome formation and secretion of pro-inflammatory cytokines (interleukin-1β and interleukin-18).
  • Overexpression of miR-451 significantly suppressed the NLRP3-induced inflammatory cascade.
  • These findings demonstrate miR-451's inhibitory effect on microglial inflammatory responses.

Conclusions:

  • MicroRNA-451 exhibits a potential anti-inflammatory role in the context of spinal cord injury.
  • Targeting the miR-451/NLRP3 pathway may offer a therapeutic strategy to mitigate secondary neuronal damage.